Imagine biting into a juicy hamburger without thinking about what happened before it reached your plate. In many intensive production systems, animals receive antibiotics not only to treat diseases, but also to accelerate weight gain.

This continuous use creates an ideal environment for the selection of resistant bacteria in the animals' intestines. From there, a chain is formed that goes beyond the limits of the farms and can reach consumers, the environment, and even those who do not eat meat.

The silent spread of resistance

The continuous use of antibiotics on farms encourages the emergence of resistant bacteria. These bacteria develop in the animals' intestines and leave the facilities through manure applied as fertilizer or during meat processing. Humans can be easily exposed, including vegetarians, since microorganisms present in feces contaminate soil, water, and crops.

Exhaust fans in pig and poultry farms also release superbugs into the air, as has already been detected outside sheds housing thousands of birds. Nearby residents can inhale these particles without realizing it, transforming entire regions into areas of higher risk for resistant infections.

What is at stake in modern medicine?

Much of contemporary medicine depends on effective antibiotics. Surgeries, transplants, and the care of premature babies are only possible thanks to the control of bacterial infections.

If resistance increases, routine procedures could become dangerous again. Simple injuries could develop into serious conditions, and hospitals would face infections that are difficult to treat. Experts warn that, without coordinated global action, decades of medical progress could be compromised.

How resistance arises in animal production.

① Routine use to promote growth

In many production systems, low doses of antibiotics are added to feed to accelerate growth. This practice is not for therapeutic purposes, but for economic reasons. Tetracycline and penicillin were widely used for this purpose. The European Union abandoned this model about 40 years ago, while other regions still maintain its use. In confined and dense environments, bacteria adapt rapidly, favoring the selection of resistant strains.

2. Direct and indirect pathways of human exposure

Intestinal bacteria are eliminated in feces, which can contaminate crops and agricultural equipment. During meat processing, microorganisms can also spread between cuts. Furthermore, runoff from farms can pollute rivers and irrigation systems, carrying pathogens to distant areas. Children and adults come into contact with contaminated soil and water, expanding the transmission cycle.

2. Evidence linking proximity and infection

Studies in the United States show an association between living near areas where pig manure is applied or large livestock operations and a higher incidence of bacterial and skin infections. Similar observations have been made in Europe, where regions with intensive pig production have recorded more human cases, even without direct contact with animals.

The European example

🔹Ban on growth promoters

The European Union decided to restrict antibiotics as growth promoters decades ago. The measure demonstrated that animal production can continue without the routine use of these drugs, while also helping to reduce the selective pressure that favors resistance.

🔹Regional impact of intensive production

In areas with a high concentration of poultry farms, European studies have detected a greater environmental presence of MRSA (methicillin-resistant Staphylococcus aureus) and an increase in human infections. The scale of production in the United States, often larger, suggests even broader challenges.

Regulatory failures and industry resistance

A report from the Pew Commission on Industrial Farm Animal Production It concluded that the current model of animal production represents an unacceptable risk to public health and recommended a ban on the non-therapeutic use of antibiotics.

In 2013 the Food and Drug Administration The FDA has published voluntary guidelines to reduce the use of these drugs as growth promoters, but the lack of legal force has drawn criticism from health experts.

Ao mesmo tempo, o United States Department of Agriculture The USDA considered reducing testing for Staphylococcus aureus in school feeding programs. Even recognizing children as a vulnerable population, economic factors continue to influence regulatory decisions.

Economy versus public health

◉ Limited financial benefit: Estimates indicate that the economic gain from using antibiotics in animal feed is approximately US$0,25 per animal. This figure raises questions about the cost-effectiveness of the practice in light of global health risks.

◉ IMinimum impact for consumers: Eliminating the non-therapeutic use of antibiotics would increase the price of meat by less than one cent per pound (454 g of meat), suggesting that the change would have little economic impact on consumers.

◉ The producer's dilemma: Experts note that farmers tend to resist change until safe and economically viable alternatives are available. This reinforces the need for investment in research and transition policies.

It's in Brazil?

In Brazil, regulation is primarily conducted by the Ministry of Agriculture and Livestock (MAPA) and the National Health Surveillance Agency (Anvisa).

Since 2020, the country has banned the use of antibiotics as growth promoters that are also considered important for human medicine, following international recommendations. Anvisa also coordinates the National Plan for the Prevention and Control of Antimicrobial Resistance, aligned with the guidelines of the World Health Organization.

The main difference is that, while in some countries the changes began through voluntary guidelines, in Brazil there were formal restrictions on certain molecules. Even so, the debate continues, especially regarding oversight, collective therapeutic use, and monitoring bacterial resistance in production chains.

The routine use of antibiotics in animal production contributes to the selection and spread of resistant bacteria that can reach humans through multiple routes. Evidence indicates an association between intensive production and an increased risk of infections from resistant strains.

At the same time, modern medicine depends on these medications to save lives every day. Protecting their effectiveness requires consistent regulatory policies, continuous monitoring, and investment in more sustainable production models.

Preserving antibiotics is not just an agricultural issue. It's a strategic decision for global health.

Source:

Videographer: https://nutritionfacts.org/video/antibiotics-agribusinesses-pound-of-flesh/

All scientific articles mentioned are available in the video description. To access them, use the "Sources Cited" tab when browsing on a computer or the "Sources" tab on the mobile version.